glp 1 popularity GLP-1 Drugs Market Size to Hit USD 132.79 Bn by 2035 Glucagon-like peptide-1 receptor: mechanisms and

Description

This triple action may reduce appetite, increase fullness, support blood sugar control and influence how the body uses energy

After consulting with a weight loss physician, I hesitantly started taking a glucagon-like peptide-1 (GLP-1) receptor agonist (Zepbound, in my case) approximately two years ago, and, in short, its been life-changing for me in the best way

But rather a combination of factors interacting over time

doi: 10.31662/jmaj.2022-0209

Even in favorable head-to-head comparisons, oral GLP-1 therapies have demonstrated weight loss outcomes of approximately 1216%, while leading injectable therapies consistently deliver around 1722% or higher